Heart valve disease occurs when heart valves do not work properly the way they should. The heart has four valves (the tricuspid, pulmonary, mitral, and aortic valves); these valves have tissue flaps that open and close at each heartbeat. The heart valve flaps make sure blood flows in the right direction through your heart's and to the rest of your body. Birth defects, age-related changes, infections, or other medical conditions can cause one or more of your heart valves to not open fully or to let blood leak back into the heart chambers. These conditions make your heart work harder and affect its ability to pump blood.
Scope of the Report:
This report focuses on the Heart Valves in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The normal invasive and MI procedures used by physicians often lead to complications like pleural effusion, arrhythmia, pleuritis, pericardial effusion, pericarditis, and infections in the lungs. This has led to physicians opting for minimally invasive catheter-based heart valve replacement surgery to reduce complications. Proven to be safe and efficient, these minimally invasive procedures reduce the need for blood transfusions, the risk of infections, hospital stays, and lead to rapid healing and recovery and better clinical outcome. As a result of their benefits, many cardiologists are opting these methods over invasive, and open heart surgeries and vendors have started manufacturing products for use during minimally invasive procedures. This increase in implementation of minimally invasive procedures is considered to be one of the primary drivers that will fuel the growth of this market in the coming years.
The demand for heart valves in the US has been rising rapidly since 2013, which will likely continue during the forecast period. The incidence of heart valve diseases in the country is rising, particularly among people aged above 70. Heart valve replacement procedures are minimally invasive and are considered safe and efficient. Many people prefer these procedures to open-heart surgeries. Favorable reimbursement coverage by Medicare governs these procedures leading many vendors to focus on launching their products in the US. These vendors are conducting clinical trials to prove their products' safety and efficacy profiles and gain FDA approvals. Approval of these devices will help in increasing the overall market revenue of heart valves in the country and boost market's growth globally.
The worldwide market for Heart Valves is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Boston Scientific Corporation
On-X Life Technologies
Micro Interventional Devices
St. Jude Medical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Transcatheter Heart Valves
Tissue Heart Valves
Mechanical Heart Valves
Market Segment by Applications, can be divided into
Ambulatory Surgical Centers
There are 15 Chapters to deeply display the global Heart Valves market.
Chapter 1, to describe Heart Valves Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Heart Valves, with sales, revenue, and price of Heart Valves, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Heart Valves, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Heart Valves market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Heart Valves sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source